Gemphire's Early-Stage Status Keeps Us Very Cautious On The IPO
June 22, 2016 at 12:54 PM EDT
Gemphire Therapeutics Inc. filed its S-1A on June 13 in advance of its June 23 IPO. GEMP hopes to raise $56.062 million in its IPO with a price range of $11 to $13 per share for its 3.75 million shares and overallotment.
